Nathan Rich
Stock Analyst at Goldman Sachs
(1.19)
# 3,713
Out of 5,180 analysts
85
Total ratings
36.51%
Success rate
-9.91%
Average return
Main Sectors:
Stocks Rated by Nathan Rich
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Maintains: Sell | $215 → $158 | $166.00 | -4.82% | 8 | Feb 17, 2026 | |
| OSCR Oscar Health | Maintains: Neutral | $16 → $21 | $10.85 | +93.55% | 6 | May 9, 2024 | |
| ZTS Zoetis | Maintains: Buy | $223 → $196 | $116.33 | +68.49% | 9 | May 6, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $34 → $30 | $11.20 | +167.86% | 8 | May 6, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6.25 → $8 | $11.95 | -33.05% | 7 | May 6, 2024 | |
| NVST Envista Holdings | Maintains: Sell | $20 → $18 | $24.26 | -27.86% | 4 | May 3, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $13 → $14 | $23.44 | -40.27% | 9 | Feb 27, 2024 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Neutral | $10 → $11 | $28.35 | -61.20% | 4 | Feb 5, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $166.26 | +35.33% | 2 | Feb 2, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $500 → $650 | $557.09 | +16.68% | 3 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $88 | $70.14 | +25.46% | 9 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $16.85 | -28.78% | 6 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $85 | $72.70 | +16.92% | 1 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $12.96 | -15.12% | 3 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $335 | $131.47 | +154.81% | 1 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $535 | $261.79 | +104.36% | 5 | Dec 14, 2021 |
Humana
Feb 17, 2026
Maintains: Sell
Price Target: $215 → $158
Current: $166.00
Upside: -4.82%
Oscar Health
May 9, 2024
Maintains: Neutral
Price Target: $16 → $21
Current: $10.85
Upside: +93.55%
Zoetis
May 6, 2024
Maintains: Buy
Price Target: $223 → $196
Current: $116.33
Upside: +68.49%
DENTSPLY SIRONA
May 6, 2024
Maintains: Neutral
Price Target: $34 → $30
Current: $11.20
Upside: +167.86%
Amneal Pharmaceuticals
May 6, 2024
Maintains: Buy
Price Target: $6.25 → $8
Current: $11.95
Upside: -33.05%
Envista Holdings
May 3, 2024
Maintains: Sell
Price Target: $20 → $18
Current: $24.26
Upside: -27.86%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13 → $14
Current: $23.44
Upside: -40.27%
Teva Pharmaceutical Industries
Feb 5, 2024
Maintains: Neutral
Price Target: $10 → $11
Current: $28.35
Upside: -61.20%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $166.26
Upside: +35.33%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500 → $650
Current: $557.09
Upside: +16.68%
May 4, 2023
Maintains: Buy
Price Target: $100 → $88
Current: $70.14
Upside: +25.46%
Apr 19, 2023
Maintains: Buy
Price Target: $14 → $12
Current: $16.85
Upside: -28.78%
Jul 21, 2022
Downgrades: Neutral
Price Target: $93 → $85
Current: $72.70
Upside: +16.92%
May 12, 2022
Maintains: Neutral
Price Target: $10 → $11
Current: $12.96
Upside: -15.12%
Dec 14, 2021
Initiates: Buy
Price Target: $335
Current: $131.47
Upside: +154.81%
Dec 14, 2021
Initiates: Buy
Price Target: $535
Current: $261.79
Upside: +104.36%